Abstract All cells release nucleotides and are in one way or another involved in local autocrine and paracrine regulation of organ function via stimulation of purinergic receptors. Significant technical advances have been made in recent years to quantify more precisely resting and stimulated adenosine triphosphate (ATP) concentrations in close proximity to the plasma membrane. These technical advances are reviewed here. However, the mechanisms by which cells release ATP continue to be enigmatic. The current state of knowledge on different suggested mechanisms is also reviewed. Current evidence suggests that two separate regulated modes of ATP release co-exist in nonexcitable cells: (1) a conductive pore which in several systems has been found to be the channel pannexin 1 and (2) vesicular release. Modes of stimulation of ATP release are reviewed and indicate that both subtle mechanical stimulation and agonist-triggered release play pivotal roles. The mechano-sensor for ATP release is not yet defined.
Introduction
The research field concerning purinergic signalling has stepped out of its infancy, and purines and their receptors are now widely accepted as an important local communication system within the body. Recent breakthroughs in this field include the role of adenosine triphosphate (ATP) as neurotransmitter and/or modulator in sensory transduction [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] , the role of released ATP as a precursor signalling molecule in renal tubulo-glomerular feedback [11, 12] , the role of released nucleotides for migrating neutrophils [13] and the crucial function of nucleotides in the control of thrombocyte aggregation and haemostasis [14] . The essential features of the purinergic signalling system are well characterised. The large family of G protein-coupled P2Y and ionotropic P2X receptors, their relevant agonists and the growing field of ecto-ATPases for the termination of the nucleotide signals are all defined.
In numerous, if not all, organ and cell systems, the purinergic system has been recognised as a local auto-and paracrine signalling network for intercellular communication. Experimental activity crossing numerous research discipline borders is rapidly extending our physiological understanding of regulated organ functions. However, one major gap prohibits us from truly appreciating the physiological and patho-physiological impact of the puringeric signalling system. This gap is our limited understanding of the pathway(s) of nucleotide release. Apparently, the source of extracellular ATP is the large pool of cytosolic ATP. In classically secreting cells like neurons and neuro-endocrine cells, ample evidence indicates that ATP release occurs via exocytosis [2, [15] [16] [17] . Cells of non-neuronal origin like epithelia, endothelial cells or astrocytes can also be stimulated to release nucleotides. The mechanism of nucleotide release from these types of cells is currently not sufficiently understood. An extensive list of mechanisms has been proposed as the general pathway for nucleotide release. The main intention of this review is to update the current state of knowledge on mechanism(s) of nucleotide release from non-neuronal or non-neuroendocrine cells. The interested reader is also directed to previous review articles which have covered many relevant aspects of cellular nucleotide release [15, [18] [19] [20] [21] . Some of the uncertainty in this field is a consequence of a limited technical repertoire to measure rapidly and precisely the concentrations of nucleotides near the plasma membrane. Therefore, this review will also describe and explain the basic principles of the different methodological approaches used so far to detect and quantify extracellular ATP. Standard biochemical methods for measuring ATP are not covered.
Methods for ATP measurements with biosensors
The principle of ATP biosensors exploits the binding or reacting property of ATP to biological molecules/receptors and a secondary signal coupled to this binding process. The biosensor can either be an ATP-dependent enzymatic reaction with subsequent measurement of the product development, an entire cell with its ATP receptors or an excised membrane patch containing ATP receptors. These three principles will be described in detail below.
The luciferin-luciferase technique
The standard technique to measure extracellular ATP in bulk solutions uses the bioluminescence of the ATPdependent luciferase-mediated oxidation of luciferin [22] . This is a straightforward and robust method using commercially available luminometers to prove the presence of ATP in a given solution, with or without cells. Other relevant nucleotide signalling molecules like uridine triphosphate (UTP), uridine diphosphate (UDP) or adenosine diphosphate (ADP) are not detected. It is exquisitely sensitive, shows fast response times (milliseconds) and a broad linear detection range and with careful optimisation allows the detection of ATP concentrations down to the femtomolar range. There are, however, many factors that interfere with the luciferase activity. The enzymatic action has its optimum at room temperature (20°C), pH 7.8 and requires Mg 2+ [23] . It is significantly inhibited by various anions (e.g. Br − , I − , NO 3 − , etc.) [24] and high salt concentrations in general [25] . The anion transport inhibitor DIDS [26] , the cation channel blocker gadolinium [27] or P2 receptor antagonist suramin [28] inhibits the luciferase reaction. All these characteristics have proven to be significant obstacles in the characterisation of the ATP release pathway(s). In cells triggered to release nucleotides, bulk extracellular ATP concentrations are commonly found to lie in the nanomolar range. Table 1 summarises some examples of extracellular ATP measurements in bulk solutions. Evidently, this method may not be very suitable to measure the 'true' ATP concentrations that a cell may encounter near the plasma membrane and does not allow the disclosure of kinetic information on ATP release because the released ATP is diluted into the relatively large surrounding fluid compartment. It needs to be appreciated that the extracellular space surrounding a cell in the native setting is very small. This contrasts with most commonly used experimental settings of cultured cells or freshly isolated tissues in which an enormous, non-physiological extracellular space is necessary to maintain homeostatic control of the experiment. Attempts to reduce the size of the extracellular fluid compartment have proven successful and show, e.g. in airway cell surface liquid layer that the hypotonicity-stimulated ATP concentration increase can be as high as 614 nM [29] . Despite this essential shortcoming, this method supplies a necessary fundamental observation because it proves the molecular identity of ATP.
Luciferase tagged to the plasma membrane
As indicated, measurements of ATP in bulk solutions do not provide sufficient information about the concentrations surrounding the purinergic receptors. In fact, measurements of ATP in bulk solution often provide no meaningful results unless ecto-ATPases are inhibited [30] . This problem has been tackled by binding firefly luciferase to surface proteins. In this way, the detecting enzyme is placed in close proximity to the plasma membrane [31, 32] . The technique exploits the strong protein binding property of bacterial protein A to IgG immunoglobulins. A protein A luciferase chimaera can be stably adsorbed onto the surface of intact cells via the binding of primary IgG antibodies directed against native surface antigens. This technique allows the detection of ten to 20 times higher peak concentrations of ATP. Thus, it has been possible to obtain a much more accurate estimate of the ATP concentrations near the plasma membrane [30, 31] . It has also provided convincing evidence that the actual concentrations of extracellular ATP during stimulation lie well within the range of nucleotide affinities of P2 receptors. Refinement of the isolation and purification procedure of the protein A chimaeric luciferase yielded a detecting enzyme with the same biological activity as the commercially available luciferase. This has significantly improved the method and allowed for robust measurements of resting and stimulated apical extracellular ATP concentrations in airway epithelial cells [32] . In addition, this study also demonstrated that reduction of the extracellular space to a minimum makes it possible to use soluble luciferase to measure the same physiological concentrations of ATP as those detected with the tagged luciferase [32] . A follow-up approach used genetically engineered biotin-linked luciferase, which was membrane-tagged via the biotinstreptavidin method [33] . Yet another approach was to create a GPI-anchored luciferase (pmeLUC), which can be stably transfected into target cells [34] . However, this luciferase construct displays low ATP sensitivity and only detects extracellular ATP values above 10 µM. Co-expression of pmeLUC with P2X 7 receptors indicated very high extracellular ATP concentrations of around 250 µM when the cells were stimulated with Bz-ATP [34] . Such high values have never been seen in other studies. The values obtained with the other tethered luciferase approaches lie two orders of magnitude lower [30] [31] [32] .
Imaging of ATP release
The luciferin/luciferase technique has been used successfully to visualise ATP release [23, 25, 26, 35, 36] . In this approach, the cells (or tissue) are bathed with the ATP-specific luminescence indicator and the ATP is imaged directly as it is being released after a given stimulus. The first successful ATP imaging was conducted by Wang and co-workers in 2000, demonstrating non-destructive cell poking-induced ATP release from astrocytes and quantifying the ATP travelling wave velocity [23] . Beautifully, this study also succeeded in semi-simultaneous detection of cellular [Ca 2+ ] i with fluo-3 [23] . Also, poking of retina glia cells showed a luminescence ATP wave propagating at similar speed to that observed with [Ca 2+ ] i imaging [35] . The luciferasegenerated light intensity is very low and requires highly sensitive imaging equipment (e.g. a nitrogen-cooled charge-coupled device (CCD) camera), together with long temporal integration, to achieve meaningful data. The achievable images are diffuse, with low spatial resolution. In the initial study, a camera integration time of 0.5 s was sufficient to detect ATP concentrations as low as 10 nM [23] . The second study also used temporal integrations of 0.5 s, together with the 2×2 binning function of a high-quality CCD camera, which was sufficient to monitor the kinetics of a 30-s period of touch-induced ATP release from glial cells [35] . A third study used cultured astrocytes, integration time of 10 s and a liquid nitrogen CCD camera to show spontaneous point source bursts of released ATP when the extracellular Ca 2+ concentration was lowered below normal physiological values (0.5 mM) [36] . Undoubtedly, this novel technical extension carries the strength of a specific signal which reports extracellular ATP concentrations directly. The low temporo-spatial resolution of the luminescence imaging technique is a significant limiting factor and may preclude the possibility of 'zooming' closer into the mechanism of ATP release. Resting or spontaneous ATP release has not so far been imaged by the luciferin-luciferase method.
Two other studies using alternative ATP-dependent enzymatic reactions were also able to detect and image extracellular ATP. One exploited the disappearance of light absorption of consumed luciferin (as substrate in the ATP-dependent luciferin-luciferase reaction) to detect muscarinic receptor-stimulated release of ATP from pancreatic acinar cells [37] . The other study imaged ATP at the leading edge of a migrating neutrophil with the use of a two-enzyme assay system which catalyses the conversion of NADP + to NADPH in the presence of ATP. The real-time generation of NADPH was measured as the appearance of NADPH fluorescence [13, 38] .
Biosensor cells and ATP detection via an increase of cytosolic Ca

2+
The use of a biosensor cell placed in the direct vicinity of an ATP-releasing cell was first introduced in 1989 by Cheek et al. who used NIH-3T3 fibroblasts co-cultured around single bovine adrenal chromaffin cells. After stimulation with nicotine, the chromaffin cells released ATP, which was sensed via a P2 receptor-dependent [Ca 2+ ] i increase by the neighbouring fibroblasts [39] . Extracellular ATP and other nucleotides commonly produce elevations of cytosolic Ca 2+ via activation of either P2Y or P2X receptors [40] . Thus, the increase of [Ca 2+ ] i is used as a read-out to measure extracellular ATP. Also, the pioneering study demonstrating the ATP dependency of travelling [Ca 2+ ] i waves in rat basophilic leukaemia cells applied this biosensor technique to substantiate ATP as a paracrine factor [41] . Later, this approach was refined by Okada and colleagues and was applied to ATP-secreting B cells from the pancreas [42] . A detailed technical note describing the essentials and features was recently published [43] . A critical issue for the biosensor cell approach is the biosensor's own susceptibility to stimuli. Thus, the experimental protocol must ascertain that an observed increase of [Ca 2+ ] i is caused by the extracellular nucleotide and not by other unidentified factors. An indicator cell can also be moved freely within the bath chamber using a micromanipulator and thereby positioned in the vicinity of the cell of interest to detect whether it releases ATP upon a given stimulus. This technique enables the researcher to answer in a convincing way the temporo-spatial characteristics of ATP release in different cells. Cultured mouse mesangial smooth muscle cells have been used as biosensors to detect ATP release from the basolateral side of rabbit renal macula densa cells [11, 17, 44] . ATP release was stimulated via an elevation of the luminal NaCl concentration without changing the environment of the biosensor cell. These findings were confirmed by PC12 cells [44] . Thus, little doubt is left that the release of ATP from the macula densa cells after exposure to high NaCl in the luminal perfusate is a key component of the tubulo-glomerular feedback mechanism [11] . Yet another example is the use of microglia cells as detectors for mechanical-induced astrocytic ATP release [45] .
P2X 2 receptor-mediated ion currents as biosensors for extracellular ATP
A similar principle of ATP biosensing uses P2X receptor-expressing cells and patch clamp recordings to measure ATP-induced inward currents either in the whole-cell configuration or in outside-out excised patches [43, 46] . It was coined the ATP 'patch sniffing' method [47] . P2X 2 receptor-expressing neuro-endocrine (PC12) cells, derived from rat phaeochromocytoma, are often used in this approach. In the PC12 cell biosensor technique, a single non-attached cell is patched and therewith hooked up to a glass pipette. After breaking the seal, ATP-induced whole-cell currents can be recorded when holding the cell at −50 mV. This technique has been successfully applied to measure stimulated ATP release from a variety of different cultured cells, including various epithelial cells (C127 mammary epithelial cancer cells, 407 intestinal epithelial cells, airway epithelial cells, renal macula densa cells), primary cultured myocardial cells and pancreatic B cells [43] and Xenopus oocytes [48] . The outside-out patch approach adds a higher degree of specificity to the system because the membrane patch, in contrast to an entire cell, is less likely to respond to other external signals and is unable to release ATP itself.
The P2X 2 receptor tagged with enhanced green fluorescence protein can also be transfected heterologously into other cells of interest, which therewith become equipped with an ATP biosensor. This has been done in insulin-secreting INS1 cells and used to show that ATP is released via exocytosis in these cells. ATP release was detected as spontaneous spiking of suramin-sensitive inward currents. This signal is also described as 'autaptic' activation of the expressed P2X 2 receptor [17] . In a similar fashion, clusters of PC12 cells display such 'autaptic' behaviour, as detected by spontaneous transient inward currents (STICs) through P2X 2 receptors. There is firm evidence that this phenomenon reflects quantal exocytotic release of ATP from PC12 cells [2] . In addition, the discovery of pannexin 1 as an ATP-releasing channel in taste bud epithelia convincingly used the P2X2/3 biosensor approach [10] . Precise quantification of extracellular ATP concentration with the cell-based biosensor approaches can be difficult because the used ATP receptors often desensitise.
The amperometric ATP biosensor microelectrode
This novel method provides hope of increasing our knowledge of ATP as a secreted extracellular molecule. It is based on an ATP biosensor built by coating a platinum microelectrode with an ultra thin layer of various enzymes [49, 50] . Different enzymes and coating protocols have successfully been used to produce functional, robust and fast-acting ATP electrodes [49, 50] . The first ATP microelectrode used immobilised glucose oxidase and hexokinase and measured ATP concentrations between 10 and 200 nM [49] . A second study used glycerol kinase (GK) and glycerol-3-phosphatase (G3P) in the enzyme layer. In the presence of glycerol, ATP leads to GK-dependent formation of glycerol-3-phosphate, which together with O 2 is converted to H 2 O 2 and glycerone phosphate by G3P. Subsequently, H 2 O 2 is oxidised at the platinum electrode (+500 mV) which provides a current signal directly proportional to the amount of consumed ATP [50] . ATP-induced current signals are linear over the physiologically relevant ATP concentration range (200 nM to 50 µM) and the microelectrode appears to be very sensitive:~250 mA M −1 cm −2 . It works robustly in physiological extracellular solutions, has the dimensions of 50 µm in diameter and 2 mm in length, and can be positioned with a micromanipulator next to the tissue. It has been used to detect ATP release during locomotor activity of the spinal cord of Xenopus embryos. It does not detect other nucleotides but may perceive disturbances from other electro-active compounds like 5HT or ascorbate [50] . Using appropriate controls with the uncoated non-sensor electrode or without glycerol, it is possible to verify that the current signals are ATP-specific. Possibly, this technique can be optimised to record only from a few or even single cells. This ATP electrode was instrumental in demonstrating recently that ATP is an important central sensory transmitter in the medulla oblongata, stimulating breathing after elevation of peripheral pCO 2 [4] . Interestingly, in a very similar fashion, the same group has also produced an adenosine electrode [51] . This has the potential of recording the ATP breakdown product adenosine and detecting the temporospatial formation of ATP and adenosine in native tissues [51] . Adaptation of the ATP electrode to micromanipulator scanning devices or even an atomic force microscope cantilever is under technical development and may evolve into an electrode-based ATP imaging method applicable to physiological preparations [52, 53] .
Other ATP biosensors An interesting methodological approach used the atomic force microscope (AFM) to scan the surface of cystic fibrosis transmembrane conductance regulator (CFTR)-expressing respiratory epithelial cells [54] . In this technique, the luminal cellular surface was scanned with the AFM cantilever. The cantilever was 'myosin-functionalised', which caused this detecting device to move slightly during myosin-induced ATP hydrolysis. Why ATPase activity produces cantilever movements is not fully explained. The ATP-induced cantilever movements were taken to indicate ATP release, and results suggest several ATP release point sources on each cell. The ATP release could be blocked by glibenclamide and was not seen in non-CFTR-expressing epithelial control cells [54] . However, no follow-up studies with this technique have been published so far, probably reflecting the significant technical difficulty and expense of this method.
Another way to exploit an ATP-dependent enzymatic reaction to measure extracellular ATP was recently reported by Yegutkin and colleagues [55] . They made use of the fact that lymphocytes express surface adenylate kinase, which generates ATP/ADP from its precursor adenosine monophosphate (AMP) [55] . Using [ 3 H]AMP and radio thin layer chromatography, they found that phosphotransfers to form ADP/ATP occurred spontaneously without added exogeneous ATP. This reaction must therefore have been driven by extracellular ATP provided by the lymphocytes themselves and was defined as the 'intrinsic' AMP phosphorylation property [56] . Quantification of this reaction can be used to calculate [ 3 H]AMP phosphorylation capacities and close estimation of the ATP concentrations necessary for this reaction. They found ATP values around 2-5 µM, which must be present to drive this reaction, and suggested that a tonically released ATP 'aura' surrounds the lymphocytes. This method provides independent evidence that extracellular ATP concentrations can reach micromolar concentrations. However, the method is probably not applicable to all cells as it relies on the surface expression of extracellular ATP-regenerating enzymes like adenylate kinases. It is not suitable for kinetic evaluations of the ATP release process.
Suggested mechanisms for cellular nucleotide release
Cytosolic ATP concentrations are high (~3 mM) and provide the source for extracellular ATP [57] . In principle, four different mechanisms may potentially be responsible for ATP release: (1) cellular lysis, necrosis and apoptosis; (2) transport via a conductive pore (channel); (3) transport via a specific solute carrier; and (4) exocytotic release. Even though the first mechanism can be relevant in some pathological states, it will not be discussed here.
A nucleotide-conductive pore ATP is a weak acid (pK a 6.9) and therefore mainly present in anionic form in the cytosol [58] . The large electrochemical, outwardly directed ATP gradient has led researchers to suggest that cells may be equipped with an ATP-conductive pore [59, 60] . This could potentially allow ATP to permeate in a regulated fashion through a plasma membrane anion/chloride channel. Molecular evidence for functionally relevant plasma membrane anion channels includes the members of the ClC chloride channel family, CFTR and the different receptor-operated chloride channels (e.g. glycine receptor) [61] . The molecular nature of the cell swelling-induced anion conductances and the Ca 2+ -activated anion conductances is still unresolved [61] . Crystal structure and electrophysiological data from ClC channels clearly exclude permeation of ATP. The large organic anion ATP is much too big to pass through the ClC pore [62, 63] . Likewise, high-resolution structural data from water and K + channels confirm that the narrow conductive pore is a general feature of ion channels [64, 65] . Thus, the available structural information on molecularly and structurally defined ion channels in general, and ClC channels in particular, do not support the proposition that the large bulky organic ion ATP can be transported through these pores.
Cell swelling-activated anion conductance
Despite the above, there is some evidence that ATP release could occur through an anion channel or pore. Numerous studies have demonstrated that cellular swelling activates a robust and large ATP release [42, [66] [67] [68] . This coincides with the fact that all cells in general react to cellular swelling with the activation of volume-sensitive anion channels [69] . Three discernible types of anion conductance are known to be activated by cellular swelling: ClC-2 channels, the volume-sensitive organic osmolyte and anion conductance (VSOAC; synonyms: VRAC, VSOR) [69] and a 'maxi' or large anion conductance. Whereas the molecular nature of VSOAC remains undefined, it has been suggested that the maxi or large anion conductance is identical to the mitochondrial voltage-dependent anion conductance (VDAC) and thus also present at the plasma membrane [69] . The ClC-2 channel is most likely not ATPpermeable, as discussed above. In contrast, VSOAC and the large anion channel show broad selective conductance, allowing different small organic anions and osmolytes to pass. VSOAC, for example, is permeable for sorbitol, various amino acids (e.g. taurine) and the methylamine betaine [69] . Okada has presented evidence that the maxi anion conductance (VDAC-like-VDACL) is a plasma membrane ATP-conductive pore in mammary cancer cells [70] and in macula densa cells [44] , and follow-up work shows that this conductance is inhibited by internal arachidonic acid [71] . VDAC is a mitochondrial ATPpermeable membrane pore, but has been suggested also to be present in the plasma membrane as a specific splice variant (pl-VDAC-1) [72] . Interestingly, VADC-1 knockout mouse tissue shows reduced mechanically stimulated ATP release and, vice versa, overexpression of pl-VDAC-1 protein in fibroblasts leads to increased mechanically stimulated ATP release [73] . Thus, these data support a role of this protein in ATP release. However, mechanically triggered ATP release continues to be present in the absence of pl-VDAC-1 [73] . Another conflicting finding regarding VDAC is its very long lag time before activation of the membrane current (>10 min) [70] , a finding which argues against its involvement in swelling-induced ATP release that always occurs promptly [67] . In addition, the other smaller conductance, outwardly rectifying VSOAC, has been suggested to mediate swelling-induced ATP release from endothelial cells. The major argument was that blockers of VSOAC currents also block ATP release [66] . Interesting follow-up work by the same authors found that swelling-induced endothelial ATP release involves Rhokinase and tyrosine-kinase [74] and suggests the following sequence of events: Cell swelling activates the RhoA/Rhokinase pathway followed by tyrosine phosphorylation of FAK and paxillin, which subsequently leads to ATP release and actin reorganisation [75] . In summary, volumeactivated anion conductances continue to be putative candidates for swelling-induced ATP secretion but this issue is far from being resolved.
The link to CFTR
The CFTR chloride channel has been suggested to conduct ATP itself or to modulate a related ATP-conductive pore [59, 60, 76, 77] . However, a significant number of studies failed to detect differences in extracellular ATP in normal and CFTR-deficient epithelial tissues [78] [79] [80] . It was also shown that swelling-induced ATP release was independent from CFTR [32, 46, 81] . Furthermore, more indirect approaches using CFTR blocking drugs failed to link agonist-stimulated ATP release to CFTR [26] . Thus, many researchers believe that CFTR is not critically involved in tonic or regulated ATP release from non-excitable cells. However, this issue continues to be controversial. Glutamate-stimulated ATP release from microglia cells is significantly attenuated in cells isolated from CFTR knockout mice [82] and erythrocytes isolated from CF patients are reported to show no mechanical-induced ATP release [83] . Thus, a final verdict on this issue is premature.
ATP release via the P2X 7 receptor
It is established that in some cells P2X 7 receptor activation with high ATP concentrations (>100-300 µM) triggers cell membrane permeabilisation to medium size molecular markers (<900 Da) [84] . It was therefore speculated that this receptor-mediated permeabilisation may also allow ATP to exit cells. Evidence for this was generated in cells which expressed membrane-bound luciferase and the P2X 7 receptor [34] . Activation of the P2X 7 receptor with Bz-ATP triggered very large increases of extracellular ATP to about 250 µM. The authors suggested that the route for ATP release is directly via the pore-forming P2X 7 receptor, but firm proof on this issue is pending. These data are contradicted by results showing that osteoblasts release the same amount of ATP by fluid shear stress, regardless of whether they express P2X 7 receptors or not [85] . It is noteworthy that the P2X 7 receptor in several cell types is associated with the induction of necrosis and apoptosis [86] . This could inevitably cause nucleotide release by a cell death mechanism and may confound the interpretation of a more direct P2X 7 receptor-mediated mechanism.
A link to connexins, pannexins and ATP-permeable hemichannels
Numerous cultured cells of different origin can be stimulated to display travelling [Ca 2+ ] i waves, a phenomenon attributed to diffusion of IP 3 through gap junctions and most intensely investigated in cultured astrocytes [87] . However, [Ca 2+ ] i waves often cross small cell-free areas and are blocked by extracellular ATP scavenging or P2 receptor blockade [88] [89] [90] . Thus, travelling [Ca 2+ ] i waves can also be caused by release of nucleotides, stimulation of P2 receptors and generation of further nucleotide release to feed wave propagation. Travelling [Ca 2+ ] i waves appear to be dependent on the expression of gap junction proteins, raising the question of whether expression of connexins may modulate nucleotide release [90, 91] . Forced expression of different connexins (Cx43, Cx32, Cx26) caused a greatly increased UTP-stimulated ATP release in different cell types [90] . It was thus speculated that the tunnelshaped connexons, which allow non-selective permeation of molecules up to the size of 1 kDa, may form a regulated exit pathway for ATP. This requires that connexin molecules, in addition to building gap junctions between cells, also localise in the plasma membrane as hemichannels. Using well-characterised antibodies against the extracellular loops of connexins, strong evidence for hemichannel localisation in cellular processes and filipodia of astrocytes has been provided [91] . Lowering extracellular Ca 2+ triggered the uptake of small (>1 kDa) fluid phase fluorophores, and this could be blocked with antibodies against connexins [91] . Thus, hemichannels have been shown to be functionally present in the plasma membrane and as a consequence of their biophysical structure could allow the exit of ATP. After lowering extracellular Ca 2+ in Cx43-expressing C6 astrocytes, ATP release from a point source cell could be imaged, and simultaneously, the entry of propidium into this ATP-releasing cell was shown [36] . These results strongly support the proposition that gap junctional hemichannels can be stimulated to open and induce ATP release. There are, however, several shortcomings in the hypothesis of connexin-mediated ATP release under physiological conditions. Most studies employing connexin activation protocols do so by removing or lowering extracellular divalent cations, a situation most unlikely to be found under physiological conditions [36, 90] . Also, very large, unphysiological depolarisation steps are necessary for the opening of these hemichannels.
Firm, unequivocal proof is lacking as to whether connexin hemichannels may open and release ATP under physiological conditions.
Recently, the novel protein family of pannexin channels has entered this field and several properties of this tunnel protein support a role in cellular ATP release [92] . Pannexins are structurally homologous to connexins and can form plasma membrane channels in Xenopus oocytes [93] [94] [95] . Several properties and findings make pannexin 1 a very attractive candidate for an ATP-releasing channel: (1) It can be activated by membrane depolarisation in the physiological range and allows permeation of small molecules including ATP [93] [94] [95] ; (2) it can be activated at normal extracellular Ca 2+ concentrations [93] ; (3) it is activated by mechanical perturbation [95] ; (4) it may open under conditions of cellular energy depletion [96] ; and (5) it can be activated by increase of intracellular Ca 2+ [95, 97] . In addition, important evidence suggests that the longsought P2X 7 -related pore structure may be pannexin 1 [98, 99] . In macrophages, pannexin 1 siRNA knockdown or a pannexin 1-mimetic inhibitory peptide blocked P2X 7 -mediated dye uptake, leaving the ion current of the P2X 7 receptors unchanged. Overexpression of pannexin 1 increased P2X 7 -meditated dye uptake [98] . Finally, there is strong evidence that taste sensation in taste bud epithelia involves pannexin 1-mediated ATP release. ATP then further stimulates the release of 5-HT from presynaptic cells within the taste bud [10] . These findings provide significant evidence that pannexins and not connexin are physiologically or patho-physiologically relevant conductive pores for ATP release.
Vesicular release of nucleotides
Vesicular release of ATP from neuronal or neuro-endocrine cells is an established phenomenon and many studies have determined ATP as a co-transmitter in peripheral and central neurons as well as from various neuro-endocrine cells. The interested reader is directed to several reviews of this area [15, 100, 101] . It is thus established that, e.g. chromaffin cells and the closely related PC12 cells store large amounts of ATP (>100 mM) together with catecholamines [2, 102] , that insulin secretion from B cells occurs together with ATP [17] and that α-dense granules in thrombocytes contain very high concentrations of ADP, a known key factor in thrombus formation [14] . There is strong evidence that astrocytic release of nucleotides under physiological conditions involves an exocytotic mechanism [45, 103, 104] , in contrast to the above-mentioned controversial issue of connexon hemichannel-mediated ATP release from astrocytes under non-physiological situations [36] . It is noteworthy that the inhibition of vesicular release with tools like brefeldin A or bafilomycin effectively inhibits travelling [Ca 2+ ] i wave propagation in astrocytes [104] . Both brefeldin A and bafilomycin have been shown to inhibit ATP release in numerous systems, supporting the notion that many non-excitable cells may be able to perform nucleotide release by this mechanism [28, 45, 82, 105] . Additional evidence supporting vesicular ATP release comes from experiments that interfere with the molecular players of constitutive and regulated exocytosis. Thus, knockdown of members of the soluble NSF attachment receptor family (SNAREs), or neurotoxins like tetanus toxin in astrocytes, inhibits nucleotide release [45, 103] . Of note is a recent observation of spontaneous autocrine quantal release of protons from HEK 293 cells, a phenomenon that may be suggested to coincide with ATP release from these vesicles [106] . Taken together, the above findings provide strong and unequivocal evidence that vesicular ATP release is a ubiquitous phenomenon of most, if not all, cells except erythrocytes [107] . The key challenge will be to unravel the physiological context in which the different organ systems 'use' vesicular ATP release to regulate a specific function. One example of this is the way in which tonic vesicular astrocytic purinergic signalling dampens neuronal synaptic networks in the CNS [103] .
Nucleotide release
Spontaneous or constitutive nucleotide release
Very low concentrations (nanomolar range) of extracellular ATP surround most, if not all, cultured cells. As externally applied ATP is rapidly broken down by ecto-ATPases on the cell plasma membranes, the stable extracellular ATP levels must reflect a steady-state situation of tonic ATP release balanced by ATP degradation at the same rate [19, 32, 56, 74] . Tonic ATP release can be unmasked by nonspecific inhibition of ecto-ATPases. Substances like ARL67156 and α,β-methylene-ATP, β,γ-methylene-ATP, ebselen or levamisole result in a slow and sustained increase of extracellular ATP concentrations [30, 32, [108] [109] [110] . Kinetic measurements of this increase allow calculation of actual cellular ATP release rates, which lie in the range of 10-500 fmol min −1 per 10 6 cells in different cell types [19] . Several findings suggest that spontaneous nucleotide release is of physiological significance. Scavenging of extracellular ATP with apyrase reduces the amount of tonically released arachidonic acid and lowers cAMP values in MDCK cells [111] . Slow spontaneous [Ca 2+ ] i oscillations in intact and cultured epithelial cells are greatly reduced in cells without relevant P2 receptors and are abrogated by ATP scavenging or pharmacological P2 receptor blockade [109] . Thus, constitutive nucleotide release appears to provide a tonic set-point regulation of a given organ function. In this context, the renal phenotype of the P2Y 2 receptor knockout mouse appears very interesting. These mice have hypertension, low plasma renin/aldosterone levels and renal hyperabsorption of Na + [112] . It is established that P2Y 2 receptor stimulation inhibits ENaCmediated Na + and aquaporin2-mediated water transport in the renal collecting duct [113] [114] [115] . The absence of this receptor in the collecting duct should therefore result in an increased Na + and H 2 O reabsorption, leading to volume expansion and reduction of the 'tonus' of the reninangiotensin-aldosterone system. Exactly, this was found in a recent publication [112] . This, however, would imply that the P2Y 2 receptors receive 'tonic' signalling input, a phenomenon, which should be preceded by tonic nucleotide release. This tonic nucleotide release can indeed be observed in cultured and intact renal epithelia [109, 111] . In summary, it is likely that control of organ function is exerted by tonic stimulation of P2 receptors. Most certainly, adenosine receptors are equally important in this scenario. [109, 117, 118] . Taken together, these findings suggest that spontaneous [Ca 2+ ] i oscillations in different cellular systems may reflect the basal property of cells to release and sense ATP.
Intracellular
Stimulated nucleotide release
Nucleotide release can be stimulated to produce rapid and transient elevation of, e.g. ATP around the cells. Two main stimulation modes are described regarding this triggered ATP release: (a) mechanical perturbation of cells, and (b) through agonists, including nucleotides themselves. These two topics will be elaborated below.
Mechanically released nucleotides
Mechanical stimulation is a common trigger for nucleotide release from most, if not all, cells [89, 90, 105, 120, 121] . This may be unphysiological, as any mechanical stimulus (e.g. poking at a cell) may cause damage and release of cellular content including ATP from the compromised cell. However, subtle non-destructive stimuli like gently rotating a dish with cultured cells [122] , increasing the flow over an epithelial/endothelial sheet, or other gentle mechanical stimuli, are prominent triggers for nucleotide release [81, [123] [124] [125] . The field of astrocyte research has provided important clues in the recognition that a single cell mechanical stimulus can lead to waves of [Ca 2+ ] i increases spreading to neighbouring cells, which is caused by the spread of released nucleotides [36, 90] . The trigger for the mechanically stimulated nucleotide release is not yet known, but it has been suggested that members of the multi-sensory TRP channel family [126] could play a pivotal role.
Fluid flow as mechanical stimulus for nucleotide release In vascular biology, evidence has accumulated that an increase of fluid flow triggers the release of ATP and pyrimidine nucleotides [123, 127, 128] . It has been suggested that the released nucleotides participate in the shear stress-induced regulation of vascular tone [40, 128] . In this model, released nucleotides bind to endothelial P2 receptors, triggering NO release and subsequent smooth muscle relaxation. A recent study has highlighted the critical role of endothelial P2X 4 receptors in flow-induced vasodilation [129] . In mice lacking P2X 4 receptors, flowinduced increases of [Ca 2+ ] i in the endothelial cells were absent, as was the endothelium-dependent vascular dilatation. Flow-induced increases in [Ca 2+ ] i can also be elicited in renal epithelia [130] [131] [132] . This phenomenon has received much attention as it was hypothesised that an absence of flow sensing in renal epithelia causes polycystic kidney disease [133] . Intriguingly, the flow-induced release of ATP from endothelial cells and the flowstimulated increase of [Ca 2+ ] i in renal epithelia show striking similarities: They are transient, gradable by the amount of applied shear stress, cause refractoriness to subsequent stimuli and are inhibited by removal of extracellular Ca 2+ [127, 134] . Recently, it was shown that the flow-induced [Ca 2+ ] i increase in intact renal tubules was caused by released nucleotides and stimulation of P2Y 2 receptors [124] . Renal research may also provide clues towards understanding the trigger mechanism for mechanically induced nucleotide release. Of note, the [Ca 2+ ] i flow response is absent or reduced in epithelia lacking the TRP channel TRPP2 [135] . Thus, this channel could be a mechano-sensor to trigger an initial Ca 2+ influx which subsequently induces nucleotide release. [67, 77, 137] . In different cells, it was also found to be inhibited by brefeldin A [77] , cytochalasin B [137] , the SNARE blocking clostridium toxin F, N-ethylmaleimide [138] and bafilomycin A1 [29] . These results strongly suggest that swelling-mediated ATP release involves an exocytotic process. The results are, however, not without conflict because it was also reported that ATP release rates in primary cultures of human bronchial epithelial cells after cell swelling were largely independent of cytosolic Ca 2+ [32] ; instead, these authors favoured the activation of an ATP-conductive pore.
In conjunction with the above discussion on ATP release via volume-sensitive anion channels ("Cell swellingactivated anion conductance" section), it needs to be realised that the mechanism of cell swelling-induced ATP release remains unresolved and controversial. The issue is further clouded by recent data from erythrocytes, which are known to be free of vesicular structures and exocytotic membrane insertions. Erythrocytes can release ATP after cell swelling, which is not thought to result from cell lysis and has been proposed to occur via pannexin 1 [107] ("A link to connexins, pannexins and ATP-permeable hemichannels" section). It is not clear whether swelling-induced ATP release and that induced by other mechanical stimuli are essentially the same, although we are inclined to assume this to be the case.
Agonist-stimulated nucleotide release
An increasing number of studies has shown that membrane receptor stimulation triggers an increase of [Ca 2+ ] i and release of ATP. Table 2 lists various examples.
Most of these receptors are GPCRs which couple to an increase of [Ca 2+ ] i via the generation of IP 3 . Direct stimulation of G proteins with GTP-γ-S or the G protein activator compound 48/80 strongly suggests that G protein activation is a pre-requisite for agonist-stimulated ATP release [26, 41] . In addition, most of these studies clearly indicated that the intracellular Ca 2+ chelator BAPTA strongly or completely inhibited the agonist-induced ATP release [26, 28, 30, 82] . Receptor-independent [Ca 2+ ] i elevations with, e.g. ionomycin or A23187 have been shown to trigger ATP release, but these are apparently poor agonists [26, 29, 67] . Inhibition of signalling events in the IP 3 pathway, such as phospholipase C using U73122, can inhibit agonist-triggered ATP release [26, 28] . Taking these findings together, it is likely that agonist signals can trigger ATP release from most, if not all, cells. The released nucleotides could then, in a positive feedback mode, amplify a cellular response. These data indicate that agonist-induced ATP release involves a vesicular release process or activates a [Ca 2+ ] i -sensitive conductive nucleotide pore (e.g. pannexin 1). Of note is the finding that agonist-and swelling-induced ATP releases were found to be additive and may therefore involve different mechanisms [30] . Finally, it is worth mentioning that aldosterone could trigger the release of basolateral ATP from frog-derived renal epithelium (A6). This phenomenon was suggested by the authors to be important for the activation of ENaCmediated Na + absorption in the distal renal tubule [139] . Figure 1 displays a simplified scheme of the cellular mode of ATP release from non-excitable cells. It assumes two major input signalling pathways to trigger ATP release. The mechano-sensor remains to be defined (black box, MS). It also assumes two major exit pathways for ATP, i.e. a conductive pore and exocytosis. The conductive pore is unknown but is shown as pannexin 1 (PX1). Intracellular Ca 2+ is crucial for regulation of both of the pathways. The big 'other' remains to be identified as described in detail in the text. The inclusion of both mechanisms in one cell is certainly not true for all cells (e.g. erythrocytes) but may be the case for many cell types.
Schematic summary
